A Therapeutic Vaccine Targeting Rat BORIS (CTCFL) for the Treatment of Rat Breast Cancer Tumors

por Loukinov, Dmitri, Anderson, Amanda Laust, Mkrtichyan, Mikayel, Ghochikyan, Anahit, Rivero-Hinojosa, Samuel, Tucker, Jo, Lobanenkov, Victor, Agadjanyan, Michael G., Nelson, Edward L.
Publicado 2023

Reducing AD-Like Pathology in 3xTg-AD Mouse Model by DNA Epitope Vaccine — A Novel Immunotherapeutic Strategy

por Movsesyan, Nina, Ghochikyan, Anahit, Mkrtichyan, Mikayel, Petrushina, Irina, Davtyan, Hayk, Olkhanud, Purevdorj B., Head, Elizabeth, Biragyn, Arya, Cribbs, David H., Agadjanyan, Michael G.
Publicado 2008

Mannan-Abeta(28 )conjugate prevents Abeta-plaque deposition, but increases microhemorrhages in the brains of vaccinated Tg2576 (APPsw) mice

por Petrushina, Irina, Ghochikyan, Anahit, Mkrtichyan, Mikayel, Mamikonyan, Grigor, Movsesyan, Nina, Ajdari, Rodmehr, Vasilevko, Vitaly, Karapetyan, Adrine, Lees, Andrew, Agadjanyan, Michael G, Cribbs, David H
Publicado 2008

The immunological potency and therapeutic potential of a prototype dual vaccine against influenza and Alzheimer's disease

por Davtyan, Hayk, Ghochikyan, Anahit, Cadagan, Richard, Zamarin, Dmitriy, Petrushina, Irina, Movsesyan, Nina, Martinez-Sobrido, Luis, Albrecht, Randy A, García-Sastre, Adolfo, Agadjanyan, Michael G
Publicado 2011

Alzheimer’s disease Advax(CpG)- adjuvanted MultiTEP-based dual and single vaccines induce high-titer antibodies against various forms of tau and Aβ pathological molecules

por Davtyan, Hayk, Zagorski, Karen, Rajapaksha, Harinda, Hovakimyan, Armine, Davtyan, Arpine, Petrushina, Irina, Kazarian, Konstantin, Cribbs, David H., Petrovsky, Nikolai, Agadjanyan, Michael G., Ghochikyan, Anahit
Publicado 2016

Humanized monoclonal antibody armanezumab specific to N-terminus of pathological tau: characterization and therapeutic potency

por Agadjanyan, Michael G., Zagorski, Karen, Petrushina, Irina, Davtyan, Hayk, Kazarian, Konstantin, Antonenko, Maxim, Davis, Joy, Bon, Charles, Blurton-Jones, Mathew, Cribbs, David H., Ghochikyan, Anahit
Publicado 2017

Expression of the Epigenetic factor BORIS (CTCFL) in the Human Genome

por de Necochea-Campion, Rosalia, Ghochikyan, Anahit, Josephs, Steven F, Zacharias, Shelly, Woods, Erik, Karimi-Busheri, Feridoun, Alexandrescu, Doru T, Chen, Chien-Shing, Agadjanyan, Michael G, Carrier, Ewa
Publicado 2011

Immunogenicity of MultiTEP-Platform-Based Recombinant Protein Vaccine, PV-1950R, Targeting Three B-Cell Antigenic Determinants of Pathological α-Synuclein

por Zagorski, Karen, Chailyan, Gor, Hovakimyan, Armine, Antonyan, Tatevik, Kiani Shabestari, Sepideh, Petrushina, Irina, Davtyan, Hayk, Cribbs, David H., Blurton-Jones, Mathew, Masliah, Eliezer, Agadjanyan, Michael G., Ghochikyan, Anahit
Publicado 2022

Novel Vaccine against Pathological Pyroglutamate-Modified Amyloid Beta for Prevention of Alzheimer’s Disease

por Zagorski, Karen, King, Olga, Hovakimyan, Armine, Petrushina, Irina, Antonyan, Tatevik, Chailyan, Gor, Ghazaryan, Manush, Hyrc, Krzysztof L., Chadarevian, Jean Paul, Davtyan, Hayk, Blurton-Jones, Mathew, Cribbs, David H., Agadjanyan, Michael G., Ghochikyan, Anahit
Publicado 2023

Targeting TLR-4 with a novel pharmaceutical grade plant derived agonist, Immunomax®, as a therapeutic strategy for metastatic breast cancer

por Ghochikyan, Anahit, Pichugin, Alexey, Bagaev, Alexander, Davtyan, Arpine, Hovakimyan, Armine, Tukhvatulin, Amir, Davtyan, Hayk, Shcheblyakov, Dmitry, Logunov, Denis, Chulkina, Marina, Savilova, Anastasia, Trofimov, Dmitry, Nelson, Edward L, Agadjanyan, Michael G, Ataullakhanov, Ravshan I
Publicado 2014

Immunogenicity of MultiTEP platform technology-based Tau vaccine in non-human primates

por Hovakimyan, Armine, Zagorski, Karen, Chailyan, Gor, Antonyan, Tatevik, Melikyan, Levon, Petrushina, Irina, Batt, Dash G., King, Olga, Ghazaryan, Manush, Donthi, Aashrit, Foose, Caitlynn, Petrovsky, Nikolai, Cribbs, David H., Agadjanyan, Michael G., Ghochikyan, Anahit
Publicado 2022

Testing a MultiTEP-based combination vaccine to reduce Aβ and tau pathology in Tau22/5xFAD bigenic mice

por Davtyan, Hayk, Hovakimyan, Armine, Kiani Shabestari, Sepideh, Antonyan, Tatevik, Coburn, Morgan A., Zagorski, Karen, Chailyan, Gor, Petrushina, Irina, Svystun, Olga, Danhash, Emma, Petrovsky, Nikolai, Cribbs, David H., Agadjanyan, Michael G., Blurton-Jones, Mathew, Ghochikyan, Anahit
Publicado 2019

A MultiTEP platform-based epitope vaccine targeting the phosphatase activating domain (PAD) of tau: therapeutic efficacy in PS19 mice

por Hovakimyan, Armine, Antonyan, Tatevik, Shabestari, Sepideh Kiani, Svystun, Olga, Chailyan, Gor, Coburn, Morgan A., Carlen-Jones, William, Petrushina, Irina, Chadarevian, Jean Paul, Zagorski, Karen, Petrovsky, Nikolai, Cribbs, David H., Agadjanyan, Michael G., Ghochikyan, Anahit, Davtyan, Hayk
Publicado 2019

Author Correction: Efficacy and immunogenicity of MultiTEP-based DNA vaccines targeting human α-synuclein: prelude for IND enabling studies

por Kim, Changyoun, Hovakimyan, Armine, Zagorski, Karen, Antonyan, Tatevik, Petrushina, Irina, Davtyan, Hayk, Chailyan, Gor, Hasselmann, Jonathan, Iba, Michiyo, Adame, Anthony, Rockenstein, Edward, Szabo, Marcell, Blurton-Jones, Mathew, Cribbs, David H., Ghochikyan, Anahit, Masliah, Eliezer, Agadjanyan, Michael G.
Publicado 2023

Induction of antitumor immunity through xenoplacental immunization

por Zhong, Zhaohui, Kusznieruk, Kornel P, Popov, Igor A, Riordan, Neil H, Izadi, Hamid, Yijian, Li, Sher, Salman, Szczurko, Orest M, Agadjanyan, Michael G, Tullis, Richard H, Harandi, Amir, Reznik, Boris N, Mamikonyan, Grigor V, Ichim, Thomas E
Publicado 2006

Efficacy and immunogenicity of MultiTEP-based DNA vaccines targeting human α-synuclein: prelude for IND enabling studies

por Kim, Changyoun, Hovakimyan, Armine, Zagorski, Karen, Antonyan, Tatevik, Petrushina, Irina, Davtyan, Hayk, Chailyan, Gor, Hasselmann, Jonathan, Iba, Michiyo, Adame, Anthony, Rockenstein, Edward, Szabo, Marcell, Blurton-Jones, Mathew, Cribbs, David H., Ghochikyan, Anahit, Masliah, Eliezer, Agadjanyan, Michael G.
Publicado 2022

Characterization and preclinical evaluation of the cGMP grade DNA based vaccine, AV-1959D to enter the first-in-human clinical trials

por Petrushina, Irina, Hovakimyan, Armine, Harahap-Carrillo, Indira S., Davtyan, Hayk, Antonyan, Tatevik, Chailyan, Gor, Kazarian, Konstantin, Antonenko, Maxim, Jullienne, Amandine, Hamer, Mary M., Obenaus, Andre, King, Olga, Zagorski, Karen, Blurton-Jones, Mathew, Cribbs, David H., Lander, Harry, Ghochikyan, Anahit, Agadjanyan, Michael G.
Publicado 2020